Back to Trades
Doshi Dipal
CEODirectorCIK 0001613084
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
Doshi Dipal, CEO, Director, has filed 4 SEC reports (2025–2026), spread across 2 companies, totaling $3.1M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Sep 3 | TRDA Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Director | Tax withheld | $62.3K |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Director | Grant | $2.8M |
| Feb 6 | AZTA Azenta, Inc. | Doshi Dipal | Insider | Grant | $157.7K |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Director | Tax withheld | $47.4K |
4 filings